Quality-adjusted survival in the first year after the acute respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 163, Issue 6, 2001, Pages 1389-1394

  Angus, D C ^a   Musthafa, A A ^a   Clermont, G ^a   Griffin, M F ^a   Linde Zwirble, W T ^a   Dremsizov, T T ^a   Pinsky, M R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY CONTROL; RESPIRATORY DISTRESS; SCORING SYSTEM; SURVIVAL RATE; WELLBEING;

EID: 0034992112     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.163.6.2005123     Document Type: Article

References (39)

1. Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome
2. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: A randomized controlled trial
3. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome
4. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome
5. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome
6. Health-related quality of life after acute lung injury
7. Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome
8. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome
9. Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients
10. Recovery of function in survivors of the acute respiratory distress syndrome
11. The effect of acute respiratory distress syndrome on long-term survival
12. Recommendations of the panel on cost-effectiveness in health and medicine
13. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial
14. The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination
15. APACHE II: A severity of disease classification system
16. A general health policy model: Update and applications
17. Measuring the quality of well-being in cystic fibrosis and lung transplantation: The importance of the area under the curve
18. Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease
19. The use of the nitrogen mustards in the palliative treatment of carcinoma
20. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
21. The quality of well-being in cystic fibrosis
22. The Beaver Dam health outcomes study: Initial catalog of health-state quality factors
23. The measurement of observer agreement for categorical data
24. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993
25. From the bench to the bedside: The future of sepsis research. Executive summary of an American College of Chest Physicians, National Institute of Allergy and Infectious Disease, and National Heart, Lung, and Blood Institute Workshop
26. Survival following mechanical ventilation for acute respiratory failure in adult men
27. Magnitude and duration of the effect of sepsis on survival
28. Predicting outcome in ICU patients. 2nd European Consensus Conference in intensive care medicine
29. Frequency and methodologic rigor of quality-of-life assessments in the critical care literature
30. Validity of the quality of well-being scale for persons with human immunodeficiency virus infection
31. Cost-effectiveness of treatments for major depression in primary care practice
32. The costs and effects of behavioral programs in chronic obstructive pulmonary disease
33. Current and projected workforce requirements for care of the critically ill and patients with pulmonary disease: Can we meet the requirements of an aging population?
34. Economic and health state utility determinations for schizophrenic patients treated with risperidone or haloperidol
35. Cost-effectiveness of captopril therapy after myocardial infarction
36. Costs and benefits of adjuvant therapy in breast cancer: A quality-adjusted survival analysis
37. The use of "quality-adjusted life years" (QALYs) to evaluate treatment in intensive care
38. A clinician's guide to cost-effectiveness analysis